Financials hVIVO plc

Equities

Market Closed - London S.E. Other stock markets 11:35:29 2024-04-26 am EDT			5-day change	1st Jan Change
28.25 ^GBX	-1.22%		+5.81%	+18.95%

Apr. 09	Transcript : HVIVO plc, 2023 Earnings Call, Apr 09, 2024
Apr. 09	HVIVO swings to profit and commences annual dividends as outlook rosy	AN

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025
Capitalization ¹	11.58	172.4	154.3	67.09	192.2	192.2	-
Enterprise Value (EV) ¹	13.81	152.8	138.9	38.65	161.6	148.4	138
P/E ratio	-1.27 x	-14.3 x	-2,300 x	-83.3 x	10.1 x	22.7 x	20.2 x
Yield	-	-	-	-	1.43%	0.83%	0.85%
Capitalization / Revenue	1.36 x	7.84 x	3.96 x	1.38 x	2.88 x	3.06 x	2.83 x
EV / Revenue	1.63 x	6.95 x	3.56 x	0.8 x	2.88 x	2.36 x	2.03 x
EV / EBITDA	-3.54 x	-22.9 x	48.1 x	4.26 x	12.4 x	10.5 x	8.9 x
EV / FCF	-4.65 x	45.6 x	-	2.64 x	14.4 x	13.1 x	9.17 x
FCF Yield	-21.5%	2.19%	-	37.8%	6.96%	7.61%	10.9%
Price to Book	2.47 x	6.45 x	-	3.32 x	6.12 x	4.02 x	3.43 x
Nbr of stocks (in thousands)	254,573	668,052	670,929	670,929	680,372	680,372	-
Reference price ²	0.0455	0.2580	0.2300	0.1000	0.2825	0.2825	0.2825
Announcement Date	6/24/20	6/17/21	6/7/22	4/25/23	4/9/24	-	-

¹GBP in Million²GBP

Estimates

Fiscal Period: December	2018	2019	2020	2021	2022	2023	2024	2025
Net sales ¹	-	8.494	22	39	48.48	56.04	62.91	67.88
EBITDA ¹	-	-3.906	-6.669	2.888	9.072	13.04	14.19	15.51
EBIT ¹	-	-4.554	-8.317	0.857	6.142	10.32	10.78	12.09
Operating Margin	-	-53.62%	-37.81%	2.2%	12.67%	18.42%	17.13%	17.82%
Earnings before Tax (EBT) ¹	-	-5.998	-11.16	0.277	-0.365	11.15	11.28	12.8
Net income ¹	-1.47	-5.929	-10.79	-0.074	-0.776	16.12	8.9	10
Net margin	-	-69.8%	-49.06%	-0.19%	-1.6%	28.75%	14.15%	14.73%
EPS ²	-6.969	-0.0359	-0.0180	-0.000100	-0.001200	0.0235	0.0124	0.0140
Free Cash Flow ¹	-	-2.97	3.353	-	14.62	10.95	11.3	15.05
FCF margin	-	-34.97%	15.24%	-	30.16%	19.27%	17.95%	22.17%
FCF Conversion (EBITDA)	-	-	-	-	161.14%	89.99%	79.61%	97.02%
FCF Conversion (Net income)	-	-	-	-	-	126.95%	126.91%	150.49%
Dividend per Share ²	-	-	-	-	-	0.004050	0.002350	0.002410
Announcement Date	6/19/19	6/24/20	6/17/21	6/7/22	4/25/23	4/9/24	-	-

¹GBP in Million²GBP

Estimates

Fiscal Period: December	2018	2019	2020	2021	2022	2023	2024	2025
Net Debt ¹	-	2.23	-	-	-	-	-	-
Net Cash position ¹	-	-	19.6	15.4	28.4	34.8	43.8	54.2
Leverage (Debt/EBITDA)	-	-0.5709 x	-	-	-	-	-	-
Free Cash Flow ¹	-	-2.97	3.35	-	14.6	10.9	11.3	15
ROE (net income / shareholders' equity)	-	-171%	-39.2%	-	30.8%	33.1%	19.9%	19.7%
ROA (Net income/ Total Assets)	-	-	-	-	-	-	-	-
Assets ¹	-	-	-	-	-	-	-	-
Book Value Per Share ²	-	0.0200	0.0400	-	0.0300	0.0500	0.0700	0.0800
Cash Flow per Share ²	-	-	-	-	-	0.0200	0.0200	0.0200
Capex ¹	-	0.02	0.82	0.74	1.36	2.25	3.89	2.03
Capex / Sales	-	0.29%	3.72%	1.89%	2.81%	3.96%	6.18%	2.99%
Announcement Date	6/19/19	6/24/20	6/17/21	6/7/22	4/25/23	4/9/24	-	-

¹GBP in Million²GBP

Estimates

Trading Rating

Investor Rating

ESG Refinitiv

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.2825 GBP

Average target price

0.3607 GBP

Spread / Average Target

+27.68%

	1st Jan change	Capi.
HVIVO PLC	+18.95%	239M
IQVIA HOLDINGS INC.	+1.51%	42.75B
MODERNA, INC.	+8.57%	41.34B
LONZA GROUP AG	+49.22%	41.61B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+8.92%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.12B
MEDPACE HOLDINGS, INC.	+29.17%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.76B
UNITED THERAPEUTICS CORPORATION	+6.35%	11B